Background
Methods/design
Study design
Participants
Panel size and recruitment
Category | Name of society |
---|---|
International dermatology societies | African Association for Dermatology |
African Dermatovenereology Association | |
Asian Academy of Dermatology and Venereology | |
Asian Dermatological Association | |
Association of French Speaking Dermatologists | |
Caribbean Dermatology Association | |
European Academy of Dermatology and Venereology (EADV) | |
European Dermatology Forum (EDF) | |
European Society for Dermatological Research (ESDR) | |
European Society for Photodermatology (ESPD) | |
Gulf Cooperation Council League of Dermatologists | |
Ibero Latin American College of Dermatology (CILAD) | |
International Forum for the Study of Itch | |
International Society of Dermatology | |
Pacific Dermatologic Association | |
Palestinian Society of Dermatology and Venereology (PSDV) | |
Pan Arab League of Dermatology | |
South Asian Regional Association of Dermatologists, Venereologists and Leprologists (SARAD) | |
Women’s Dermatologic Society | |
International dermatology special interest societies | European Dermato-Epidemiology Network (EDEN) |
European Taskforce on Atopic Dermatitis (ETFAD) | |
Harmonising Outcome Measures for Eczema (HOME) | |
International Eczema Council (IEC) | |
International Society of Atopic Dermatitis (ISAD) | |
European Registry of Psoriasis (PSONET) | |
Dermatology nursing societies | Australian Dermatology Nurses’ Association (ADNA) |
British Dermatological Nursing Group (BDNG) | |
Dermatology Nurses Association (DNA) | |
International Skin Care Nursing Group (ISNG) | |
Paediatric dermatology societies | British Society of Paediatric Dermatology (BSPD) |
Deutsche Gesellschaft für Kinder- und Jugendmedizin e.V. (DGKJ) | |
European Society of Paediatric Dermatology (ESPD) | |
French Society for Pediatric Dermatology | |
International Society of Paediatric Dermatology (ISPD) | |
Japanese Society of Pediatric Dermatology | |
Latin American Pediatric Dermatology Society | |
Nederlands-Belgische vereniging voor Kinderdermatologie (Kinderhuid) | |
Society for Pediatric Dermatology (SPD) | |
National dermatology societies | Algerian Society of Dermatology |
American Academy of Dermatology (AAD) | |
American Dermatological Association (ADA) | |
Argentine Society of Dermatology (SAD) | |
Asociacion Colombiana de Dermatoloiga y Cirugia Dermatologica (AsoColDerma) | |
Asociacion Ecuatoriana de Dermatologia y Ciencias Afines (AEDCA) | |
Asociacion Guatemalteca De Dermatologia | |
Association of Dermato-Venerologists of Latvia (BADV) | |
Association of Italian Clinical Dermatologists (AIDA) | |
Association of the Italian Women Dermatologists (DDI) | |
Association of Professors of Dermatology USA (APD) | |
Australasian College of Dermatologists (ACD) | |
Austrian Society for Dermatology and Venereology (OEGDV) | |
Belarusian Society of Dermatovenereologists and Cosmetologists | |
Belgian Society of Dermatology and Venereology | |
Brazilian Society of Dermatology (SBD) | |
British Association of Dermatologists (BAD) | |
Bulgarian Dermatological Society | |
Canadian Dermatology Association (CDA) | |
Chilean Society of Dermatology and Venereology | |
Chinese Society of Dermatology (CSD) | |
Croatian Dermatovenerological Society of the Croatian | |
Cyprus Society of Dermatology and Venereology | |
Czech Academy of Dermatovenereology (CADV) | |
Czech Dermatovenereology Society (CDS) | |
Dansk Dermatologisk Selskab (DDS) | |
Dermatologic Society of Iceland | |
Dermatological Society of Malaysia (PDM) | |
Dermatological Society of Mauritius | |
Dermato-venereology Senegalese Society | |
Dermatological Society of Singapore (DSS) | |
Dermatological Society of South Africa (DSSA) | |
Dermatological Society of Thailand (DST) | |
Dermatovenereology Association of Turkey | |
Dutch Society of Dermatology and Venereology (NVDV) | |
Eczema Clinical Network New Zealand | |
Egyptian Society of Aesthetic Dermatology | |
Finnish Society of Dermatology (Suomen Ihotautilääkäriyhdistys) (SILY) | |
French Society of Dermatology (SFD) | |
Georgian Association of Dermatology and Venereology (GADV) | |
German Dermatological Society (DDG) | |
Hellenic Society of Dermatology and Venereology (EDAE) | |
Honduran Society of Dermatology and Dermatologic Surgery | |
Hong Kong College of Dermatologists (HKCD) | |
Hong Kong Society of Dermatology and Venereology (HKSDV) | |
Hungarian Dermatological Society (MDT) | |
Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) | |
Indonesian Society of Dermatology and Venereology (PERDOSKI) | |
Iranian Society of Dermatology | |
Irish Association of Dermatologist | |
Israel Society of Dermatology and Venereology (ISDV) | |
Italian Association of Hospital Dermatologists (ADOI) | |
Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA) | |
Italian Society of Dermatology (SIDeMaST) | |
Ivoirienne Society of Dermatology and Venereology (SIDV) | |
Japanese Dermatological Association (JDA) | |
Japanese Organization of Clinical Dermatologists (JOCD) | |
Japanese Society for Investigative Dermatology | |
Jordanian Society for Dermatology and Venereology (JSDV) | |
Korean Dermatological Association (KDA) | |
Kuwait Society of Dermatologists (KSD) | |
Lebanese Dermatological Society | |
Libyan Society of Dermatology and Venereology | |
Maltese Association of Dermatology and Venereology | |
Mexican Academy of Dermatology (AMD) | |
Mexican Society of Dermatology (SMDAC) | |
Mongolian Dermatological Society | |
Moroccan Society of Dermatology (SMD) | |
New Zealand Dermatological Society Inc. (NZDS) | |
Nicaraguan Association of Dermatology | |
Nigerian Association of Dermatologists (NAD) | |
Norwegian Society of Dermatology and Venereology (NSDV) | |
Oman Dermatology Society (ODS) | |
Pakistan Association of Dermatologists (PAD) | |
Paraguayan Society of Dermatology | |
Peruvian Society of Dermatology (SPD) | |
Philippine Academy of Clinical and Cosmetic Dermatology (PACCD) | |
Philippine Dermatological Society (PDS) | |
Polish Dermatological Society (PTD) | |
Portuguese Society of Dermatology and Venereology (SPDV) | |
Romanian Society of Dermatology (SRD) | |
Russian Society of Dermatovenerologists and Cosmetologists (RODV) | |
Salvadorian Association of Dermatology | |
Saudi Society of Dermatology and Dermatologic Surgery (SSDDS) | |
Serbian Association of Dermatovenereologists | |
Slovak Dermatovenereological Society (SDVS) | |
Sociedad Ecuatoriana de Dermatologia | |
Society of Dermatologists, Venereologists and Leprologists of Nepal (SODVELON) | |
Society of Dermatovenereology Turkey (TURKDERM) | |
Society for Investigative Dermatology USA (SID) | |
Spanish Academy of Dermatology and Venereology (AEDV) | |
Sri Lanka College of Dermatologists (SLCD) | |
Sudanese Association of Dermatology | |
Swedish Society for Dermatology and Venereology (SSDV) | |
Swiss Society of Dermatology and Venereology (SGDV/SSDV) | |
Syrian Arab Society of Dermatology | |
Taiwanese Dermatological Association | |
Tunisian Society of Dermatology and Venereology | |
Turkish Society of Dermatology (TDD) | |
UK Translational Research Network in Dermatology (UK TREND) | |
Uruguayan Dermatological Society (SDU) | |
Venezuelan Society of Dermatology and Dermatologic Surgery (SVDCD) | |
Vietnamese Society of Dermatology and Venereology (NIDV) | |
Allergy and contact dermatitis societies | Dutch Society of Allergology (NVVA) |
European Environmental and Contact Dermatitis Research Group (EECDRG) | |
European Research Group on Experimental Contact Dermatitis (ERGECD) | |
European Society of Contact Dermatitis (ESCD) | |
European Surveillance System on Contact Allergies (ESSCA) | |
Irish Food Allergy Network (IFAN) |
Name of society |
---|
Allergy New Zealand (NZ) |
Association Française de l’Eczéma (FR) |
Eczema – an Indian Perspective (IDA) |
Eczema Association of Australasia (AU) |
Eczema Association of Kenya (KE) |
Eczema Outreach Scotland (UK, Scotland) Eczema Scotland (UK, Scotland) |
Irish Skin Foundation (IE) |
Itchy Kids New Zealand (NZ) |
La Prévention des Allergies (BE) |
Malta Eczema Society (MT) |
National Eczema Society (UK) |
National Eczema Association (US) |
South African National Eczema Association (SANEA) (ZA) |
Swiss Allergy Centre (CH) |
Talkhealth Partnership (UK) |
The Eczema Society of Canada (CA) |
Vereniging Mensen met Constitutioneel Eczeem (VMCE) (NL) |
eDelphi questionnaire
Domains | Domain items |
---|---|
Demographics | Social history |
Marital history | |
Past AE treatments | Previous topical treatments for AE |
Previous day hospital care treatments for AE | |
Previous hospitalisation for AE | |
Previous structured education programme for AE | |
Current AE treatments | Topical treatments |
Allergy test results | Delayed contact hypersensitivity patch test |
Atopy patch test | |
Double-blind, placebo-controlled food challenge | |
Skin-prick testing to foods or aeroallergens | |
Chronic (inflammatory) comorbidities | Inflammatory bowel disease |
Rheumatoid arthritis | |
Diabetes mellitus | |
Smoking/alcohol/recreational drug history | Smoking history |
Alcohol intake | |
Recreational drug history (soft drugs) | |
Current concomitant medication (i.e. other than specific AE medication | Antihistamines, oral or topical |
Topical antibiotics | |
Oral antibiotics | |
Allergic rhinoconjunctivitis medication | |
Asthma medication | |
Baseline physical examination | Fitzpatrick skin type |
Weight and height for BMI calculation | |
Blood pressure | |
Body temperature | |
Chest (lung) auscultation | |
Heart auscultation | |
Lymph node palpation (axillary and inguinal) | |
Skin examination | |
Baseline physician and patient reported domains | Physician-assessed clinical signs, e.g. EASI or SCORAD score |
Investigator/physician global assessment, e.g. IGA | |
Patient-reported symptoms, e.g. POEM, itch or sleep score | |
Patient global assessment, e.g. PGA | |
Generic quality of life score | |
Dermatology-specific quality of life score | |
AE-specific quality of life score | |
Patient-reported satisfaction with AE care received | |
Baseline investigations and assessments | Blood testing for past/current tuberculosis |
Chest radiograph | |
Hepatitis B status | |
Hepatitis C status | |
Human immunodeficiency virus (HIV) status | |
Varicella zoster virus (VZV) immune status | |
Pregnancy | |
Monitoring P3NP in case of methotrexate use in adults | |
Evaluating TPMT level prior to azathioprine use | |
Collection of medical photographs to monitor disease extent | |
Baseline biorepository samples | Collection of blood for biomarkers, e.g. TARC |
Collection of DNA (blood or saliva) for filaggrin analysis | |
Collection of biomaterials, e.g. DNA, PBMC or skin biopsy, for a biorepository | |
Baseline management | Reasons for choosing specific treatment (systemic or phototherapy) |
Routine recording of relative contraindication(s) for selected treatment | |
Follow-up general questions | Minimum follow-up frequency for registry data entry, once stable therapeutic dose has been reached: |
A. 2 months | |
B. 3 months | |
C. 4 months | |
D. 5 months | |
E. 6 months | |
Minimum follow-up frequency for registry data entry, after stopping photo- or systematic therapy: | |
A. 3 months | |
B. 6 months | |
C. Annually | |
D. No follow-up | |
Follow-up physical examination | Weight and height for BMI calculation |
Blood pressure | |
Body temperature | |
Chest (lung) auscultation | |
Heart auscultation | |
Lymph node palpation (axillary and inguinal) | |
Skin examination | |
Follow-up physician- and patient-reported domains | Physician-assessed clinical signs, e.g. EASI or SCORAD score |
Investigator/physician global assessment, e.g. IGA | |
Patient-reported symptoms, e.g. POEM, itch or sleep score | |
Patient global assessment, e.g. PGA | |
Generic quality of life score | |
Dermatology-specific quality of life score | |
AE-specific quality of life score | |
Reporting of disease control, e.g. flares, fully controlled weeks, by physician | |
Reporting of disease control, e.g. flares, fully controlled weeks, by patient | |
Adherence to treatment between appointments | |
Patient-reported satisfaction with AE care received | |
Follow-up investigations and assessments | Minimum frequency of safety investigations: |
A. 6 weeks | |
B. 8 weeks | |
C. 10 weeks | |
D. 12 weeks | |
E. 14 weeks | |
F. 16 weeks | |
Collection of medical photographs to monitor disease extent | |
Follow-up biorepository samples | Collection of blood for biomarkers, e.g. TARC |
Collection of biomaterials, e.g. DNA, PBMC or skin biopsy, for a biorepository |
Domains | Domain items |
---|---|
Related to baseline ‘demographics and AE’ | |
Demographics | Date of birth and date of enrolment into registry |
Gender | |
Ethnicity | |
Educational status | |
Current occupation or education | |
AE diagnosis | How diagnosis AE is established |
Use of validated diagnostic criteria | |
Date of onset AE | |
Past AE treatments | Previous phototherapy |
Previous systemic therapy | |
Current AE treatments | Phototherapy |
Systemic immunosuppressive therapy | |
Family history of AE or allergic diseases | |
Related to baseline ‘past medical relevant history’ | |
Allergic comorbidities | Asthma |
Allergic rhinoconjunctivitis | |
Atopic eye disease | |
Eosinophilic oesophagitis | |
Food allergies | |
Contact allergies | |
Other comorbidities | Past malignancies |
Past serious infections | |
Related to baseline ‘investigations and assessments’ | |
Baseline safety investigations | Medical history (tuberculosis) |
Full blood count | |
Liver function | |
Kidney profile | |
Related to follow-up visits | |
Follow up ‘adverse drug reactions’ | |
Serious adverse events | |
Adverse events that cause stop or switch of therapy or change in dosage | |
For (serious) adverse events: probability of relationship with treatment | |
Follow-up ‘management’ | |
Reason for switching therapy | |
Reason for discontinuation of therapy |